2005
DOI: 10.1002/lt.20497
|View full text |Cite|
|
Sign up to set email alerts
|

Neonatal hemochromatosis - medical treatment vs. transplantation: The king's experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
100
1
3

Year Published

2005
2005
2014
2014

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 86 publications
(106 citation statements)
references
References 26 publications
(36 reference statements)
1
100
1
3
Order By: Relevance
“…Survival rates with this treatment regimen were dismal with rates as low as 10-20%. [45][46][47] After the discovery that NH was caused by GALD, a new treatment regimen was initiated utilizing the combination of double-volume exchange transfusion to remove existing reactive antibody followed immediately by administration of high-dose intravenous immunoglobulin (IVIG) (1 g/kg) to block antibody induced complement activation. The published experience with this treatment regimen shows marked improvement in survival compared to historical controls.…”
Section: Treatmentmentioning
confidence: 99%
See 1 more Smart Citation
“…Survival rates with this treatment regimen were dismal with rates as low as 10-20%. [45][46][47] After the discovery that NH was caused by GALD, a new treatment regimen was initiated utilizing the combination of double-volume exchange transfusion to remove existing reactive antibody followed immediately by administration of high-dose intravenous immunoglobulin (IVIG) (1 g/kg) to block antibody induced complement activation. The published experience with this treatment regimen shows marked improvement in survival compared to historical controls.…”
Section: Treatmentmentioning
confidence: 99%
“…48 Historically, NH is a frequent indication for liver transplantation in the first 3 months of life. 46 However, transplantation is extremely challenging in these patients given their frequent history of prematurity, small size, and multiorgan failure. 49 The overall survival of infants receiving a liver transplant for the indication of NH is approximately 35%.…”
Section: Treatmentmentioning
confidence: 99%
“…Mogelijk dat het starten van de behandeling binnen twee tot drie dagen de prognose wel kan verbeteren. 9,10,22 Levertransplantatie is op dit moment de enige echte behandeling van NH. Na transplantatie is de leveraandoening verdwenen, een recidief na transplantatie is slechts eenmaal beschreven.…”
Section: Patiëntunclassified
“…23 De overlevingskans is echter niet hoog en de patiënten die overleefden hadden vaak neurologische beperkingen. 9,17 Samenvattend kan gezegd worden dat NH een zeldzame aandoening is, maar een relatief vaak voorkomende oorzaak van neonataal leverfalen. Herkenning van het beeld is niet altijd gemakkelijk.…”
Section: Patiëntunclassified
“…Il propose l'association de mé dicaments antioxydants, de ché lateurs du fer et de cyto-protecteurs [10] mais n'en a pas ré ellement modifié le pronostic (Tableau 1) [11,12]. Seule la transplantation hé patique pré coce a pu montrer une efficacité un peu plus probante mais elle expose à d'autres complications [13].…”
Section: Introductionunclassified